Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Satellos Bioscience Inc. (MSLE) had Free Cash Flow of $-23.60M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.30M |
|
-- |
|
-- |
|
$7.65M |
|
$-7.65M |
|
$0.40M |
|
$-7.25M |
|
$-7.25M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.65M |
|
$-7.65M |
|
14.60M |
|
14.60M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$31.88M |
|
$0.01M |
|
$0.01M |
|
$31.89M |
|
$4.11M |
|
-- |
|
-- |
|
$4.11M |
|
$27.78M |
|
$27.78M |
|
$27.78M |
|
15.46M |
|
| Cash Flow Statement Financials | |
$-23.60M |
|
$-9.42M |
|
$2.24M |
|
$40.07M |
|
$9.80M |
|
$-30.27M |
|
$3.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-23.60M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.28% |
|
-26.28% |
|
-22.90% |
|
-26.28% |
|
$1.80 |
|
$-1.62 |
|
$-1.62 |
|